Observational studyJournal of Crohn's & colitis2026
Quality metrics reflecting patient experience of gastrointestinal endoscopy in inflammatory bowel disease: results of national endoscopy dataset analysis.
Observational study in Journal of Crohn's & colitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe European Society of Gastrointestinal Endoscopy has recently defined important performance measures for endoscopy in inflammatory bowel disease (IBD). The role of patient experience in quality assessment of endoscopy in IBD has yet to be defined. We undertook an observational study based on analysis of a large multi-center dataset with national coverage in Ireland. The aim was to analyze individual and composite metrics that reflect patients' experience with endoscopic procedures for IBD.
methodsAnonymized data were extracted from electronic procedure records of patients who underwent colonoscopy in 24 Irish hospitals. The performance indicator of colonic intubation (PICI), a novel composite score reflecting sedation rates and patient comfort, and IBD-specific endoscopic domains were evaluated.
resultsData from 261 524 colonoscopies were analysed from 2014 to 2020. Crohn's disease (CD) patients had a significantly lower odds ratio (OR) of achieving PICI compared to non-IBD patients (0.69, 0.65-0.74, P < .001). Severe colitis was also associated with a significantly lower OR of achieving PICI (OR 0.53, 0.38-0.74, P < .001). In total, 80.2% of CD patients had a comfort score ≤2 compared to 87.8% of those with ulcerative colitis (UC) and 84.2% without IBD. Additionally, 60.7% of patients with CD required a midazolam dose of 3 mg or more compared to 50.4% of those with UC and 76.7% of those without IBD. In total, 50% of CD patients required fentanyl doses >50 µg compared to 34% of UC patients and 30.3% of patients without IBD.
conclusionThis analysis of a large national endoscopy dataset highlights variability in quality metrics for IBD endoscopy and underscores the need for a metric such as PICI to more accurately capture and reflect patient endoscopic experience with IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.